Prescrire Int. 2015 May;24(160):118-9.
No comparative trials versus well-established drugs; worrisome risk of bronchospasm; unsuitable mode of administration for agitated, often uncooperative patients.
与成熟药物相比无对照试验;存在令人担忧的支气管痉挛风险;对于烦躁不安、通常不合作的患者给药方式不合适。